Effects of Zoledronic Acid on Breast Cancer Cells
Author Information
Author(s): Denoyelle C, Hong L, Vannier J-P, Soria J, Soria C
Primary Institution: Laboratoire DIFEMA, Groupe de Recherche MERCI, UFR de Medecine et de Pharmacie, Rouen, France
Hypothesis
Can zoledronic acid inhibit the invasion and proliferation of breast cancer cells through RhoA-dependent mechanisms?
Conclusion
Zoledronic acid inhibits the invasion of breast cancer cells and reduces their chemotactic response to SDF-1 by affecting RhoA signaling and CXCR-4 expression.
Supporting Evidence
- Zoledronic acid significantly reduced the invasion of MDA-MB-231 cells by 62.1% at a concentration of 1μM.
- High concentrations of zoledronic acid (100μM) induced apoptosis in breast cancer cells.
- Zoledronic acid inhibited the expression of u-PAR, which is crucial for cancer cell invasion.
- Treatment with zoledronic acid decreased CXCR-4 expression on MDA-MB-231 cells from 59.8% to 15.7%.
Takeaway
Zoledronic acid helps stop breast cancer cells from spreading and growing by messing with their movement and how they respond to signals.
Methodology
The study used the MDA-MB-231 breast cancer cell line to assess the effects of zoledronic acid on cell proliferation, invasion, and signaling pathways.
Limitations
The study primarily used in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website